Reply to Letter to the Editor: “Patients with uncertain advanced fibrosis and cirrhosis diagnosis by Agile3+ and Agile4 scores cannot be excluded in validation studies” Posted on 7 February 2024 by nSatoshi Oeda, nHirokazu Takahashin Hepatology Research, EarlyView.
Patients with uncertain advanced fibrosis and cirrhosis diagnosis by Agile3+ and Agile4 scores cannot be excluded in validation studies Posted on 13 December 2023 by Hepatology Research, EarlyView.
Three‐dimensional reconstruction of eccrine poroma vessels seen under reflectance confocal microscopy Posted on 26 September 2023 by
NOD2 at the interface of hidradenitis suppurativa and inflammatory bowel disease—An in silico analysis Posted on 11 September 2023 by nDillon Mintoff, nIsabella Borg, nNikolai P. Pacen Experimental Dermatology, EarlyView.
Integrative prediction of metabolic dysfunction‐associated fatty liver disease by endogenous fructose and related metabolism Posted on 19 August 2023 by nHsien‐Hui Chungn Hepatology Research, EarlyView.
Reply to Nwanaji‐Enwerema, 2023, “Exposome and low birthweight selection bias considerations in early life infections and epigenetic age relationships” Posted on 9 August 2023 by American Journal of Human Biology, EarlyView.
Exposome and low birthweight selection bias considerations in early life infections and epigenetic age relationships Posted on 2 August 2023 by nJamaji C. Nwanaji‐Enweremn American Journal of Human Biology, EarlyView.
Neoadjuvant treatment of basosquamous carcinomas with Sonidegib: An innovative approach Posted on 11 July 2023 by Experimental Dermatology, EarlyView.
“Superresponders” at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors Posted on 26 December 2022 by Experimental Dermatology, EarlyView.
Reply to Vargas, Peirano et al. Posted on 14 November 2022 by nGon Shoham, nAriel Berl, nOfir Shir‐az, nSharon Shabo, nAvshalom Shalomn Experimental Dermatology, EarlyView.